CJC-1295 vs Sermorelin

Reviewed by Gabriel Brocklesby · Last updated

Both are growth hormone-releasing peptides used in hormone optimisation and longevity clinic contexts. Compare clinic profiles by protocol transparency and clinician oversight.

CJC-1295 and sermorelin are commonly referenced in hormone optimisation and longevity clinics. Providers vary in dosing rationale and monitoring standards. Use this comparison to assess clinical governance.

CJC-1295

A growth hormone secretagogue referenced in longevity and hormone optimisation listings.

Potential benefits

  • Often part of GH secretagogue protocols.
  • Common in performance and longevity clinics.

Considerations

  • Evidence base varies by clinic.
  • Monitoring standards differ.
Best for: Comparing hormone optimisation clinics and their oversight.

Sermorelin

A growth hormone–releasing hormone analogue listed in longevity protocols.

Potential benefits

  • Referenced in hormone optimisation pathways.
  • Often grouped with other secretagogues.

Considerations

  • Clinical context varies widely.
  • Requires structured assessment.
Best for: Evaluating clinics that list GH secretagogues.
CategoryCJC-1295Sermorelin
Directory contextInformational clinic and treatment comparison context.Informational clinic and treatment comparison context.
Common goalsCompare how clinics frame suitability, monitoring, and expected use cases.Compare how clinics frame suitability, monitoring, and expected use cases.
Guidance noteInformational listing only; suitability requires clinician review.Informational listing only; suitability requires clinician review.

Next step

Compare clinics offering these treatments

Use city pages and peptide-specific pages to move from general research into actual provider shortlists. That usually gives a better buying picture than comparing drug names alone.

Related clinics

FeaturedVerified

Menon Health

London, United Kingdom

Menon Health is a Mayfair-based peptide therapy clinic founded by Dr Mukil Menon, a GMC-registered physician and one of the first doctors to prescribe medical peptide therapy in the UK. Before establishing Menon Health, Dr Menon served as UK medical director at Koniver Wellness, launching the clinic at Soho House London. He continues to practise within the NHS alongside his private consultations, ensuring his protocols stay grounded in current medical standards. The clinic offers doctor-led, prescription-based peptide therapy alongside regenerative cell complex treatments, bloods and diagnostics, and IV therapy. All formulations are sourced from GMP-certified, EMA-regulated pharmacies and dispensed as pre-filled pens, vials, or multi-peptide syringes — Menon Health's approach to combining multiple peptides in a single dose is designed to improve precision and patient adherence. Based at 64 North Row in Mayfair, London, Menon Health serves patients across the UK, Europe, Canada, and the United States, with consultations available in person or remotely.

In personRemoteFrom £195Virtual consultations
View ProfileSend EnquiryCompare

Conclusion

Both appear in similar clinic contexts; choose based on provider quality and monitoring standards rather than the peptide name alone.

Related peptide pages

US city pages

For clinics

Are you a clinic?

Get featured on this page and reach patients actively looking for peptide therapy, GLP-1 treatments, recovery support, and longevity care.